Providers can breathe a sigh of relief as a split House and Senate likely means that most of the sweeping healthcare policy changes are off the table until 2020. Plus, they may join forces with lawmakers on a common enemy: Pharma.
Providers poised to pounce on midterm results for pharma beatdown
